Tyramine

• USES: • For the temporary relief from symptoms including: • neurological support • anxiety • appetite control • hives • lethargy • poor memory • mood swings • travel sickness These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

1. 1Drug Ineffective415%
2. 2Fall415%
3. 3Acute Kidney Injury311%
4. 4Balance Disorder311%
5. 5Chronic Kidney Disease311%
6. 6End Stage Renal Disease311%
7. 7General Physical Health Deterioration311%
8. 8Mobility Decreased311%
9. 9Renal Failure311%
10. 10Arthralgia27.4%
11. 11Asthenia27.4%
12. 12Condition Aggravated27.4%
13. 13Device Issue27.4%
14. 14Fatigue27.4%
15. 15Feeling Abnormal27.4%

Recent PubMed references pinned to Tyramine as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Effects of Latilactobacillus fuchuensis and marination on spoilage and tyramine formation in rainbow trout packaged under modified atmosphere.
  Food microbiology · 2026 · Johansson P, Säde E, Adhikari L, et al.
  PMID 42215236DOI 10.1016/j.fm.2026.105160
• Near-infrared reinforced alginate-tyramine-curcumin gels for alleviation of osteoarthritis in an ACLT murine model.
  Journal of materials chemistry. B · 2026 · Tsai YT, Tseng YW, Chen YT, et al.
  PMID 42065458DOI 10.1039/d5tb00975h
• A positive feedback loop between sensory and octopaminergic neurons underlies nociceptive plasticity in Drosophila larvae.
  PLoS genetics · 2026 · Boivin JC, Zhao YQ, Zhu J, et al.
  PMID 42048383DOI 10.1371/journal.pgen.1012122
• Cross-Platform Neurotransmitter & Alias Ambiguity for OA-AL2b1 and OA-AL2b2 Neurons in Drosophila melanogaster.
  Neuroinformatics · 2026 · Olivera RA
  PMID 42043632DOI 10.1007/s12021-026-09783-4
• Selective octopaminergic tuning of mushroom body circuits during memory formation.
  Proceedings of the National Academy of Sciences of the United States of America · 2026 · Franke US, Großjohann A, Aurich S, et al.
  PMID 41980099DOI 10.1073/pnas.2517403123
• Beyond Solanaceae: incorporation of feruloyltyramine and feruloyloctopamine into Cannabaceae lignins.
  Plant physiology · 2026 · Rencoret J, Martín-Alvarado D, Ralph J, et al.
  PMID 41978523DOI 10.1093/plphys/kiag202
• Injectable double-crosslinked oxidized dextran/ gelatin-tyramine hydrogel loaded with in-situ synthesized HA on COOH-MWCNTs to enhance osteogenesis and angiogenesis.
  Carbohydrate polymers · 2026 · Liu X, Liu L, Yang L, et al.
  PMID 41943346DOI 10.1016/j.carbpol.2026.125052
• A Wearable Supramolecular Fingertip Sensor for Colorimetric Detection of Food-Derived Tyramine.
  Analytical chemistry · 2026 · Li S, Lin X, Zhou Z, et al.
  PMID 41911060DOI 10.1021/acs.analchem.5c08158

The 10 most recently updated of 22 ClinicalTrials.gov registrations naming Tyramine as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• siRNA Microneedle Patches for Earlobe Keloid Post-Surgical Scars
  Not yet recruiting · Phase 2 · Interventional · 158 enrolled · Ong Kim Yao
  NCT07596628updated 2026-05-22
• Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
  Not yet recruiting · Phase 2 · Phase 3 · Interventional · 1,120 enrolled · Applied Biology, Inc.
  NCT06648850updated 2026-04-13
• Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)
  Completed · Phase 1 · Phase 2 · Interventional · 93 enrolled · Memorial Sloan Kettering Cancer Center
  NCT02315326updated 2026-02-02
• Combination HTNV and PUUV DNA Vaccine
  Completed · Phase 1 · Interventional · 61 enrolled · U.S. Army Medical Research and Development Command
  NCT03718130updated 2025-06-26
• Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
  Not yet recruiting · Phase 3 · Interventional · 140 enrolled · Applied Biology, Inc.
  NCT06762548updated 2025-05-23
• A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participants
  Completed · Phase 1 · Interventional · 52 enrolled · Janssen Research & Development, LLC
  NCT02608320updated 2025-02-03
• Dietary Supplementation on Fat Oxidation
  Recruiting · Interventional · 16 enrolled · Brightseed
  NCT06548048updated 2024-08-12
• Berberine and Cinnamon in Management of Diabetes
  Completed · Interventional · 44 enrolled · National Nutrition and Food Technology Institute
  NCT05570357updated 2024-06-11
• Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants
  Completed · Phase 1 · Interventional · 128 enrolled · Celgene
  NCT04978298updated 2023-08-31
• Levomilnacipran in Healthy Males
  Unknown · Phase 4 · Interventional · 36 enrolled · University of Ottawa
  NCT03249311updated 2021-10-06

Frequently asked questions

What is Tyramine used for?

According to FDA labeling, Tyramine carries indications including: USES: • For the temporary relief from symptoms including: • neurological support • anxiety • appetite control • hives • lethargy • poor memory • mood swings • travel sickness These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.